QA: AVEO Pharmaceuticals INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001325879_2021_AVEO_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001325879, AVEO Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 65,508,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 343,000
3 remainder_Assets 1,061,000
4 LiabilitiesCurrent 16,945,000
5 LiabilitiesNoncurrent 1,957,000
6 remainder_Liabilities 12,716,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 26,463,113
9 ResearchAndDevelopmentExpense 22,822,515
10 remainder_Expenses 0
11 remainder_Revenues 13,202,191
12 remainder_NetIncome 5,917,493
13 remainder_ComprehensiveNetIncome -315
  yvar yval
0 Assets 66,912,000
1 Liabilities 31,618,000
2 Expenses 49,285,628
3 Revenues 13,202,191
4 StockholdersEquity 35,294,000
5 NetIncome -30,165,944
6 ComprehensiveNetIncome -30,166,102
7 BaseVar 83,467,814
8 EconomicCapitalRatiobeforeLimitedLiability 0.949
9 EconomicCapitalRatio 2.26

Edgar->Model Mapping

Feature Distribution

Change over Time